TerrAscend Corp. (OTCMKTS:TSNDF - Get Free Report) was the recipient of a significant decline in short interest during the month of May. As of May 15th, there was short interest totalling 1,956,500 shares, a decline of 12.3% from the April 30th total of 2,230,400 shares. Based on an average daily trading volume, of 1,480,900 shares, the days-to-cover ratio is presently 1.3 days. Approximately 1.0% of the shares of the company are sold short.
Analyst Ratings Changes
Separately, Atb Cap Markets raised TerrAscend from a "hold" rating to a "strong-buy" rating in a report on Thursday, May 8th.
Get Our Latest Report on TerrAscend
TerrAscend Stock Performance
TSNDF traded down $0.02 on Friday, reaching $0.27. The company had a trading volume of 636,851 shares, compared to its average volume of 635,039. TerrAscend has a fifty-two week low of $0.23 and a fifty-two week high of $1.75. The stock has a market cap of $81.54 million, a P/E ratio of -1.01 and a beta of 1.43. The company's fifty day moving average is $0.35 and its 200 day moving average is $0.51. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.69 and a current ratio of 1.35.
TerrAscend (OTCMKTS:TSNDF - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.02). TerrAscend had a negative net margin of 23.95% and a negative return on equity of 31.48%. The firm had revenue of $71.00 million during the quarter, compared to analyst estimates of $71.63 million. As a group, analysts predict that TerrAscend will post -0.14 earnings per share for the current fiscal year.
About TerrAscend
(
Get Free Report)
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.
Further Reading
Before you consider TerrAscend, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TerrAscend wasn't on the list.
While TerrAscend currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
